Pro Share Advisors LLC Madrigal Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 4,598 shares of MDGL stock, worth $1.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,598

Previous 3,298 39.42%

Holding current value

$1.6 Million

Previous $923,000 5.63%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$212.22 - $292.96 $275,886 - $380,848	1,300 Added 39.42%	4,598 $975,000
Q2 2024 Aug 13, 2024	SELL	$193.33 - $291.99 $146,157 - $220,744	-756 Reduced 18.65%	3,298 $923,000
Q1 2024 May 08, 2024	BUY	$171.37 - $283.23 $58,779 - $97,147	343 Added 9.24%	4,054 $1.08 Million
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $88,373 - $174,053	734 Added 24.66%	3,711 $858,000
Q3 2023 Nov 13, 2023	BUY	$146.04 - $225.78 $3,212 - $4,967	22 Added 0.74%	2,977 $434,000
Q2 2023 Aug 10, 2023	BUY	$203.88 - $312.0 $40,572 - $62,088	199 Added 7.22%	2,955 $682,000
Q1 2023 May 11, 2023	SELL	$231.06 - $307.08 $68,624 - $91,202	-297 Reduced 9.73%	2,756 $667,000
Q4 2022 Feb 02, 2023	BUY	$58.39 - $296.54 $178,264 - $905,336	3,053 New	3,053 $886,000
Q2 2022 Aug 01, 2022	SELL	$58.04 - $100.2 $230,767 - $398,395	-3,976 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$55.89 - $101.89 $56,057 - $102,195	-1,003 Reduced 20.14%	3,976 $391,000
Q4 2021 Feb 08, 2022	SELL	$72.34 - $95.09 $1,446 - $1,901	-20 Reduced 0.4%	4,979 $422,000
Q3 2021 Nov 12, 2021	SELL	$78.35 - $105.02 $72,630 - $97,353	-927 Reduced 15.64%	4,999 $399,000
Q2 2021 Aug 13, 2021	BUY	$97.2 - $137.59 $133,552 - $189,048	1,374 Added 30.18%	5,926 $577,000
Q1 2021 May 14, 2021	BUY	$108.54 - $125.2 $24,530 - $28,295	226 Added 5.22%	4,552 $532,000
Q4 2020 Feb 09, 2021	BUY	$110.06 - $133.7 $476,119 - $578,386	4,326 New	4,326 $481,000
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $108,227 - $246,146	-1,142 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$207.3 - $300.31 $77,944 - $112,916	376 Added 49.09%	1,142 $245,000
Q2 2018 Aug 13, 2018	BUY	$101.55 - $313.9 $77,787 - $240,447	766 New	766 $214,000

Others Institutions Holding MDGL

# of Institutions

296

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Madrigal Pharmaceuticals, Inc. Transaction History